{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T16:34:56Z","timestamp":1784738096445,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.cyto.2025.156997","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T21:28:35Z","timestamp":1753219715000},"page":"156997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Assessment of Cancer biomarkers and biochemical parameters across breast Cancer stages: Correlation with age and comorbidities"],"prefix":"10.1016","volume":"194","author":[{"given":"Omeed","family":"Darweesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed K.J.","family":"Alnori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2025.156997_bb0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.breast.2018.03.002","article-title":"Global analysis of advanced\/metastatic breast cancer: decade report (2005\u20132015)","volume":"39","author":"Cardoso","year":"2018","journal-title":"The Breast."},{"key":"10.1016\/j.cyto.2025.156997_bb0015","series-title":"The Global Concern for cancer Emergence and its Prevention: A Systematic Unveiling of the Present Scenario","first-page":"1429","author":"Ghufran","year":"2023"},{"key":"10.1016\/j.cyto.2025.156997_bb0020","series-title":"Prognostic and predictive biomarkers in breast cancer: Past, present and future. Seminars in cancer biology","author":"Nicolini","year":"2018"},{"issue":"6","key":"10.1016\/j.cyto.2025.156997_bb0025","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/CCO.0000000000000006","article-title":"Current status of interleukin-10 and regulatory T-cells in cancer","volume":"25","author":"Dennis","year":"2013","journal-title":"Curr. Opin. Oncol."},{"issue":"7","key":"10.1016\/j.cyto.2025.156997_bb0030","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.21873\/anticanres.15110","article-title":"Cytokine-based cancer immunotherapy: challenges and opportunities for IL-10","volume":"41","author":"Rallis","year":"2021","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.cyto.2025.156997_bb0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4103\/tcmj.tcmj_162_20","article-title":"Interleukin-10: a double-edged sword in breast cancer","volume":"33","author":"Chang","year":"2021","journal-title":"Tzu chi medical journal."},{"issue":"7","key":"10.1016\/j.cyto.2025.156997_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133830","article-title":"Elevated levels of serum tumor markers CEA and CA15-3 are prognostic parameters for different molecular subtypes of breast cancer","volume":"10","author":"Shao","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.cyto.2025.156997_bb0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.breast.2013.11.003","article-title":"Serum levels of CEA and CA15-3 in different molecular subtypes and prognostic value in Chinese breast cancer","volume":"23","author":"Wu","year":"2014","journal-title":"Breast"},{"issue":"23\u201324","key":"10.1016\/j.cyto.2025.156997_bb0050","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.cca.2010.08.039","article-title":"CA 15-3: uses and limitation as a biomarker for breast cancer","volume":"411","author":"Duffy","year":"2010","journal-title":"Clin. Chim. Acta"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2025.156997_bb0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.mrfmmm.2011.06.016","article-title":"Plasma antioxidant enzymes and clastogenic factors as possible biomarkers of colorectal cancer risk","volume":"714","author":"Maffei","year":"2011","journal-title":"Mutation Research\/Fundamental and Molecular Mechanisms of Mutagenesis."},{"key":"10.1016\/j.cyto.2025.156997_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr1647","article-title":"Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity","volume":"9","author":"Stillfried","year":"2007","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.cyto.2025.156997_bb0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0090-8258(88)90044-3","article-title":"Lactic dehydrogenase, alkaline phosphatase and human chorionic gonadotropin in a pure ovarian dysgerminoma","volume":"30","author":"Dgani","year":"1988","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cyto.2025.156997_bb0070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cca.2022.05.029","article-title":"Molecular markers in cancer","volume":"532","author":"Ahmad","year":"2022","journal-title":"Clin. Chim. Acta"},{"issue":"9","key":"10.1016\/j.cyto.2025.156997_bb0075","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/bjc.2012.128","article-title":"Gamma-glutamyl transferase: risk and prognosis of cancer","volume":"106","author":"Fentiman","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cyto.2025.156997_bb0080","article-title":"Evaluation of some proinflammatory cytokines and biochemical parameters in pre and postmenopausal breast cancer women","volume":"179","author":"Bakheet","year":"2024","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cyto.2025.156997_bb0085","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.mce.2013.03.024","article-title":"Cytokines driving breast cancer stemness","volume":"382","author":"Chin","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.cyto.2025.156997_bb0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up\u2606","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.cyto.2025.156997_bb0095","doi-asserted-by":"crossref","first-page":"594","DOI":"10.6004\/jnccn.2023.0031","article-title":"NCCN guidelines\u00ae insights: breast cancer, version 4.2023","volume":"21","author":"William","year":"2023","journal-title":"J Natl Compr Canc Ne."},{"key":"10.1016\/j.cyto.2025.156997_bb0100","article-title":"CREB1-BCL2 drives mitochondrial resilience in RAS GAP-dependent breast cancer chemoresistance","volume":"1-13","author":"Man","year":"2025","journal-title":"Oncogene"},{"issue":"1012","key":"10.1016\/j.cyto.2025.156997_bb0105","first-page":"2025","article-title":"IL-10-directed Cancer immunotherapy: preclinical advances, clinical insights, and future perspectives","volume":"17","author":"El-Shemi","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.cyto.2025.156997_bb0110","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1093\/ajcp\/aqad150.080","article-title":"Carcinoembryonic antigen (CEA) expression in human tumors: a tissue microarray study on 15,413 tumors","volume":"160","author":"Jansen","year":"2023","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.cyto.2025.156997_bb0115","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/annonc\/mdt490","article-title":"Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer","volume":"25","author":"Orlandi","year":"2014","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.cyto.2025.156997_bb0120","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.7150\/jca.26853","article-title":"Prognostic value of ferritin-to-hemoglobin ratio in patients with advanced non-small-cell lung cancer","volume":"10","author":"Lee","year":"2019","journal-title":"J. Cancer"},{"issue":"6","key":"10.1016\/j.cyto.2025.156997_bb0125","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1476-5586(03)80034-9","article-title":"The transferrin receptor: a potential molecular imaging marker for human cancer","volume":"5","author":"H\u00f6gemann-Savellano","year":"2003","journal-title":"Neoplasia"},{"issue":"23","key":"10.1016\/j.cyto.2025.156997_bb0130","doi-asserted-by":"crossref","first-page":"11238","DOI":"10.1158\/0008-5472.CAN-06-1278","article-title":"Macrophages regulate the angiogenic switch in a mouse model of breast cancer","volume":"66","author":"Lin","year":"2006","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.cyto.2025.156997_bb0135","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ncb3341","article-title":"Glutathione biosynthesis is a metabolic vulnerability in PI (3) K\/Akt-driven breast cancer","volume":"18","author":"Lien","year":"2016","journal-title":"Nat. Cell Biol."},{"issue":"10","key":"10.1016\/j.cyto.2025.156997_bb0140","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1038\/s41418-019-0276-y","article-title":"Glutathione S-transferases P1 protects breast cancer cell from adriamycin-induced cell death through promoting autophagy","volume":"26","author":"Dong","year":"2019","journal-title":"Cell Death & Differentiation."},{"issue":"4","key":"10.1016\/j.cyto.2025.156997_bb0145","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.4314\/ijbcs.v16i4.1","article-title":"Lactate dehydrogenase (LDH) and evaluation of response to breast cancer chemotherapy","volume":"16","author":"Soudre","year":"2022","journal-title":"Int. J. Biol. Chem. Sci."},{"key":"10.1016\/j.cyto.2025.156997_bb0150","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s10120-018-0897-8","article-title":"Prognostic significance of serum alkaline phosphatase and lactate dehydrogenase levels in patients with unresectable advanced gastric cancer","volume":"22","author":"Namikawa","year":"2019","journal-title":"Gastric Cancer"},{"issue":"12","key":"10.1016\/j.cyto.2025.156997_bb0155","doi-asserted-by":"crossref","first-page":"10714","DOI":"10.18632\/oncotarget.24246","article-title":"An explorative analysis of the prognostic value of lactate dehydrogenase for survival and the chemotherapeutic response in patients with advanced triple-negative breast cancer","volume":"9","author":"Jia","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.cyto.2025.156997_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278454","article-title":"Liver function indicators in patients with breast cancer before and after detection of hepatic metastases-a retrospective study","volume":"18","author":"Leser","year":"2023","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.cyto.2025.156997_bb0165","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1016\/j.jhep.2023.07.002","article-title":"Elevated liver function tests in a patient with breast cancer","volume":"79","author":"Neftel","year":"2023","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.cyto.2025.156997_bb0170","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3892\/mco.2014.419","article-title":"Association of CA 15-3 and CEA with clinicopathological parameters in patients with metastatic breast cancer","volume":"3","author":"Geng","year":"2015","journal-title":"Molecular and clinical oncology."},{"issue":"1","key":"10.1016\/j.cyto.2025.156997_bb0175","doi-asserted-by":"crossref","DOI":"10.5644\/ama2006-124.125","article-title":"Tumor marker CA 15-3 in breast cancer patients","volume":"44","author":"Fejzi\u0107","year":"2015","journal-title":"Acta medica academica."},{"issue":"3","key":"10.1016\/j.cyto.2025.156997_bb0180","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/iub.1721","article-title":"Low BMI is correlated with increased TGF-\u03b2 and IL-10 mRNA levels in the peripheral blood of breast cancer patients","volume":"70","author":"Liu","year":"2018","journal-title":"IUBMB Life"},{"key":"10.1016\/j.cyto.2025.156997_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12863-015-0234-8","article-title":"The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients","volume":"16","author":"Korobeinikova","year":"2015","journal-title":"BMC Genet."},{"key":"10.1016\/j.cyto.2025.156997_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr1648","article-title":"Oestrogen receptor negative breast cancers exhibit high cytokine content","volume":"9","author":"Chavey","year":"2007","journal-title":"Breast Cancer Res."},{"issue":"7","key":"10.1016\/j.cyto.2025.156997_bb0195","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3390\/cancers14071681","article-title":"Dual effect of immune cells within tumour microenvironment: pro-and anti-tumour effects and their triggers","volume":"14","author":"Pe\u00f1a-Romero","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.cyto.2025.156997_bb0200","article-title":"Interleukin-10 overexpression in 4T1 cells: a gateway to suppressing mammary carcinoma growth","volume":"142","author":"Wang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cyto.2025.156997_bb0205","article-title":"Recent progress and challenges in biosensing of carcinoembryonic antigen","volume":"117964","author":"Babazad","year":"2024","journal-title":"TrAC Trends Anal. Chem."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625001449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625001449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T20:33:26Z","timestamp":1755808406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466625001449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":40,"alternative-id":["S1043466625001449"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2025.156997","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of Cancer biomarkers and biochemical parameters across breast Cancer stages: Correlation with age and comorbidities","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2025.156997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156997"}}